Advanced Search

 

Study ID Status Title Patient Level Data
712753/009 Completed A 24 week, randomised, double blind, parallel study to compare the change in HbA1c with AVANDAMET® (8.0mg / 2.0g) plus insulin to placebo plus insulin, in subjects with type 2 diabetes starting insulin therapy Study Listed on ClinicalStudyDataRequest.com
719125/002 Completed A multicenter Phase I open-label dose-escalation vaccine trial of dHER2 protein with AS15 adjuvant in HER2-overexpressing patients with high-risk breast cancer
743921/001 Completed A Phase I Study to Determine the Safety and Pharmacokinetics of Intravenous Administration of SB743921 on a Once Every 3 Week Schedule in Patients with Solid Tumors
759346 Completed Evaluate the feasibility of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC vaccine administered as a 3 dose primary vaccination course at 6, 10 & 14 weeks of age
759346/002 Completed Assess immune persistence & memory by giving plain PRP,PSA & PSC (10 mths age), & immunogenicity & safety of a Tritanrix™-HBV/Hib-MenAC/ Tritanrix™-HBV/Hib2.5 booster (15-18 mths age) in previously primed subjects Study Listed on ClinicalStudyDataRequest.com
759346/004 Completed Assess reactogenicity and safety of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC compared to Tritanrix™-HepB/Hiberix™ (control) in healthy infants (2,4,6 months age), after a hepatitis B birth dose
759346/007 Completed Demonstrate non-inferiority of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ with respect to anti-HBs immune response, when given to healthy infants at 6,10 & 14 weeks age, after a birth dose of hepatitis B vaccine Study Listed on ClinicalStudyDataRequest.com
773812/003 Completed A placebo controlled, double-blind, randomised study investigating the safety, tolerability and pharmacokinetics of ascending multiple oral doses of SB-773812 in male and female schizophrenic patients for up to 28 days
773812/007 Completed A Parallel Study to Investigate Dopaminergic D2 and Serotoninergic 5HT2A Receptor Occupancy at Stable Plasma Concentrations of SB-773812 after Repeated Doses in Schizophrenic Patients. Relationship with Pharmacokinetics and Efficacy Readouts.
776423/001 Completed A phase III, observer-blinded randomised, multi-centre clinical study of the safety, immunogenicity and consistency of three manufacturing lots of GSK Biologicals' candidate Tdap vaccine as compared to a US-licensed Td vaccine when given as a booster dose to healthy adolescents (10-18 years of age) Study Listed on ClinicalStudyDataRequest.com
792014/001 Completed A phase II, open (partially double-blind), randomised, controlled, multicentre, primary vaccination study to evaluate the immunogenicity (including immune memory), reactogenicity and safety of three different formulations of the GSK Biologicals’ combined Haemophilus influenzae type b-meningococcal serogroups CY conjugate vaccine given concomitantly with Infanrix® penta and Prevenar®, versus ActHIB® and Meningitec® given concomitantly with Infanrix® penta and versus ActHIB® given concomitantly with Infanrix® penta and Prevenar® in infants according to a 2-4-6 month schedule. Study Listed on ClinicalStudyDataRequest.com
792014/003 Completed A phase II, open (partially double-blind), randomised, controlled, multicentre, primary vaccination study to evaluate the immunogenicity, reactogenicity and safety of three different formulations of GSK Biologicals’ combined Haemophilus influenzae type b-meningococcal serogroups C and Y- conjugate vaccine and one formulation of GSK Biologicals’ Haemophilus influenzae type b-meningococcal serogroup C conjugate vaccine each given concomitantly with InfanrixTM penta, versus MeningitecTM, given concomitantly with InfanrixTM hexa in infants according to a 2-3-4 month schedule Study Listed on ClinicalStudyDataRequest.com
999910/193 Completed Prospective, Hospital-based, Multicentre Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
999920/040 Completed A study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients
A1900832 Completed A Pharmacokinetic Study to Evaluate the Rate and Extent of Absorption of Paracetamol from Two Formulations in an Indian Population.
A1901106 Completed A Study to Investigate the Gastrointestinal Safety of OTC Analgesics in Healthy Volunteers by Endoscopic Examination
A1A20004 Completed A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Tolerability of a 14 Day Treatment Course of GW493838 50mg Compared to Placebo in Subjects with Peripheral Neuropathic Pain
A2260597 Terminated A study to assess the efficacy of paracetamol taken in combination with caffeine for the treatment of episodic tension type headache
A2260665 Completed A pivotal pharmacokinetic study investigating the extent of absorptions of paracetamol and caffeine for two different paracetomol formulations containing caffeine
A2750596 Completed A study investigating the pharmacokinetic profiles of four extended release paracetamol formulations
A2750605 Completed A single dose PK study investigating the extent of paracetamol absorption from two different sustained released paracetamol formulations
A2750606 Completed A single dose PK study investigating the extent of paracetamol absorption from two sustained release paracetamol formulations
A2750607 Completed A repeat dose PK study investigating the extent of paracetamol absorption from two sustained release paracetamol formulations
A2750894 Completed A Proof of Principal Study to Investigate the Pharmacokinetic Profiles of Sustained Release and Standard Paracetamol Formulations
A3360529 Completed A randomised, double-blind, evaluation of the effects of paracetamol on the BOLD fMRI response to painful stimuli in subjects with osteoarthritis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.